Depletion of β-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer

Sandeep K. Raghuwanshi, Mohd W. Nasser, Xiaoxin Chen, Robert M. Strieter, Ricardo M. Richardson

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Arrestins are adaptor/scaffold proteins that complex with activated and phosphorylated G protein-coupled receptor to terminate G protein activation and signal transduction. These complexes also mediate downstream signaling, independently of G protein activation. We have previously shown that β-arrestin-2 (βarr2) depletion promotes CXCR2-mediated cellular signaling, including angiogenesis and excisional wound closure. This study was designed to investigate the role of βarr2 in tumorigenesis using a murine model of lung cancer. To that end, heterotopic murine Lewis lung cancer and tail vein metastasis tumor model systems in βarr2-deficient mice (βarr2 -/-) and control littermates (βarr2 +/+) were used. βarr2 -/- mice exhibited a significant increase in Lewis lung cancer tumor growth and metastasis relative to βarr2 +/+ mice. This correlated with decreased number of tumorinfiltrating lymphocytes but with elevated levels of the ELR + chemokines (CXCL1/keratinocyte-derived chemokine and CXCL2/ MIP-2), vascular endothelial growth factor, and microvessel density. NF-κB activity was also enhanced in βarr2 -/- mice, whereas hypoxia-inducible factor-1α expression was decreased. Inhibition of CXCR2 or NF-κB reduced tumor growth in both βarr2 -/- and βarr2 +/+ mice. NF-κB inhibition also decreased ELR + chemokines and vascular endothelial growth factor expression. Altogether, the data suggest that βarr2 modulates tumorigenesis by regulating inflammation and angiogenesis through activation of CXCR2 and NF-κB. The Journal of Immunology,

Original languageEnglish (US)
Pages (from-to)5699-5706
Number of pages8
JournalJournal of Immunology
Volume180
Issue number8
StatePublished - Apr 15 2008

Fingerprint

Lung Neoplasms
Growth
Neoplasms
GTP-Binding Proteins
Vascular Endothelial Growth Factor A
Carcinogenesis
Chemokine CXCL1
Arrestins
beta-Arrestin 1
Chemokine CXCL2
Neoplasm Metastasis
Hypoxia-Inducible Factor 1
Lymphocyte Count
G-Protein-Coupled Receptors
Microvessels
Allergy and Immunology
Chemokines
Tail
Veins
Signal Transduction

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Raghuwanshi, S. K., Nasser, M. W., Chen, X., Strieter, R. M., & Richardson, R. M. (2008). Depletion of β-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer. Journal of Immunology, 180(8), 5699-5706.

Depletion of β-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer. / Raghuwanshi, Sandeep K.; Nasser, Mohd W.; Chen, Xiaoxin; Strieter, Robert M.; Richardson, Ricardo M.

In: Journal of Immunology, Vol. 180, No. 8, 15.04.2008, p. 5699-5706.

Research output: Contribution to journalArticle

Raghuwanshi, SK, Nasser, MW, Chen, X, Strieter, RM & Richardson, RM 2008, 'Depletion of β-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer', Journal of Immunology, vol. 180, no. 8, pp. 5699-5706.
Raghuwanshi, Sandeep K. ; Nasser, Mohd W. ; Chen, Xiaoxin ; Strieter, Robert M. ; Richardson, Ricardo M. / Depletion of β-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer. In: Journal of Immunology. 2008 ; Vol. 180, No. 8. pp. 5699-5706.
@article{877bf86dcb7347f4b65611b30e8dfd5a,
title = "Depletion of β-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer",
abstract = "Arrestins are adaptor/scaffold proteins that complex with activated and phosphorylated G protein-coupled receptor to terminate G protein activation and signal transduction. These complexes also mediate downstream signaling, independently of G protein activation. We have previously shown that β-arrestin-2 (βarr2) depletion promotes CXCR2-mediated cellular signaling, including angiogenesis and excisional wound closure. This study was designed to investigate the role of βarr2 in tumorigenesis using a murine model of lung cancer. To that end, heterotopic murine Lewis lung cancer and tail vein metastasis tumor model systems in βarr2-deficient mice (βarr2 -/-) and control littermates (βarr2 +/+) were used. βarr2 -/- mice exhibited a significant increase in Lewis lung cancer tumor growth and metastasis relative to βarr2 +/+ mice. This correlated with decreased number of tumorinfiltrating lymphocytes but with elevated levels of the ELR + chemokines (CXCL1/keratinocyte-derived chemokine and CXCL2/ MIP-2), vascular endothelial growth factor, and microvessel density. NF-κB activity was also enhanced in βarr2 -/- mice, whereas hypoxia-inducible factor-1α expression was decreased. Inhibition of CXCR2 or NF-κB reduced tumor growth in both βarr2 -/- and βarr2 +/+ mice. NF-κB inhibition also decreased ELR + chemokines and vascular endothelial growth factor expression. Altogether, the data suggest that βarr2 modulates tumorigenesis by regulating inflammation and angiogenesis through activation of CXCR2 and NF-κB. The Journal of Immunology,",
author = "Raghuwanshi, {Sandeep K.} and Nasser, {Mohd W.} and Xiaoxin Chen and Strieter, {Robert M.} and Richardson, {Ricardo M.}",
year = "2008",
month = "4",
day = "15",
language = "English (US)",
volume = "180",
pages = "5699--5706",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "8",

}

TY - JOUR

T1 - Depletion of β-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer

AU - Raghuwanshi, Sandeep K.

AU - Nasser, Mohd W.

AU - Chen, Xiaoxin

AU - Strieter, Robert M.

AU - Richardson, Ricardo M.

PY - 2008/4/15

Y1 - 2008/4/15

N2 - Arrestins are adaptor/scaffold proteins that complex with activated and phosphorylated G protein-coupled receptor to terminate G protein activation and signal transduction. These complexes also mediate downstream signaling, independently of G protein activation. We have previously shown that β-arrestin-2 (βarr2) depletion promotes CXCR2-mediated cellular signaling, including angiogenesis and excisional wound closure. This study was designed to investigate the role of βarr2 in tumorigenesis using a murine model of lung cancer. To that end, heterotopic murine Lewis lung cancer and tail vein metastasis tumor model systems in βarr2-deficient mice (βarr2 -/-) and control littermates (βarr2 +/+) were used. βarr2 -/- mice exhibited a significant increase in Lewis lung cancer tumor growth and metastasis relative to βarr2 +/+ mice. This correlated with decreased number of tumorinfiltrating lymphocytes but with elevated levels of the ELR + chemokines (CXCL1/keratinocyte-derived chemokine and CXCL2/ MIP-2), vascular endothelial growth factor, and microvessel density. NF-κB activity was also enhanced in βarr2 -/- mice, whereas hypoxia-inducible factor-1α expression was decreased. Inhibition of CXCR2 or NF-κB reduced tumor growth in both βarr2 -/- and βarr2 +/+ mice. NF-κB inhibition also decreased ELR + chemokines and vascular endothelial growth factor expression. Altogether, the data suggest that βarr2 modulates tumorigenesis by regulating inflammation and angiogenesis through activation of CXCR2 and NF-κB. The Journal of Immunology,

AB - Arrestins are adaptor/scaffold proteins that complex with activated and phosphorylated G protein-coupled receptor to terminate G protein activation and signal transduction. These complexes also mediate downstream signaling, independently of G protein activation. We have previously shown that β-arrestin-2 (βarr2) depletion promotes CXCR2-mediated cellular signaling, including angiogenesis and excisional wound closure. This study was designed to investigate the role of βarr2 in tumorigenesis using a murine model of lung cancer. To that end, heterotopic murine Lewis lung cancer and tail vein metastasis tumor model systems in βarr2-deficient mice (βarr2 -/-) and control littermates (βarr2 +/+) were used. βarr2 -/- mice exhibited a significant increase in Lewis lung cancer tumor growth and metastasis relative to βarr2 +/+ mice. This correlated with decreased number of tumorinfiltrating lymphocytes but with elevated levels of the ELR + chemokines (CXCL1/keratinocyte-derived chemokine and CXCL2/ MIP-2), vascular endothelial growth factor, and microvessel density. NF-κB activity was also enhanced in βarr2 -/- mice, whereas hypoxia-inducible factor-1α expression was decreased. Inhibition of CXCR2 or NF-κB reduced tumor growth in both βarr2 -/- and βarr2 +/+ mice. NF-κB inhibition also decreased ELR + chemokines and vascular endothelial growth factor expression. Altogether, the data suggest that βarr2 modulates tumorigenesis by regulating inflammation and angiogenesis through activation of CXCR2 and NF-κB. The Journal of Immunology,

UR - http://www.scopus.com/inward/record.url?scp=45949097905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45949097905&partnerID=8YFLogxK

M3 - Article

C2 - 18390755

AN - SCOPUS:45949097905

VL - 180

SP - 5699

EP - 5706

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 8

ER -